Compare McKesson Corporation (MCK) vs PulteGroup, Inc. (PHM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs PulteGroup, Inc. — how do they compare? McKesson Corporation trades at $824.8 (market cap $97.35B), while PulteGroup, Inc. trades at $123.56 (market cap $23.46B). The key difference: McKesson Corporation is far larger — about 4.1× PulteGroup, Inc.'s market cap, and PulteGroup, Inc. pays the higher dividend (0.84%). Which is the better fit depends on your goals.
| MCK | PHM | |
|---|---|---|
Market Cap | $97.35B | $23.46B |
Sector | Health | Consumer Cyclical |
52-Week High | $995.69 | $142.56 |
52-Week Low | $659.01 | $108.65 |
Enterprise Value | $101.98B | $23.42B |
Dividend Yield | 0.39% | 0.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
PulteGroup (PHM) trades at $123.12, down 2.35% today, with a bullish technical signal from moving averages but neutral oscillators. The stock shows solid fundamentals with a P/E of 12.19, net income margin of 12.14%, and positive cash flow trends, though recent earnings missed expectations in two of the last three quarters. Recent news highlights mixed investor sentiment amid mortgage rate concerns and new community developments, with a dividend payment scheduled for July 2, 2026.
Outlook is cautiously optimistic with a consensus price target of $146.50, implying 19% upside, supported by strong institutional holdings and a GF Score of 93. Key risks include high mortgage rates pressuring margins and volatile housing demand. The stock's current level near the analyst low target of $123.00 suggests potential support, but earnings performance in the upcoming Q2 report will be critical for momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About PulteGroup, Inc.
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →
